Braun, J., Loyal, L., Frentsch, M., Wendisch, D., Georg, P., Kurth, F., Hippenstiel, S., Dingeldey, M., Kruse, B., Fauchere, F., Baysal, E., Mangold, M., Henze, L., Lauster, R., Mall, M.A., Beyer, K., Röhmel, J., Voigt, S., Schmitz, J. and Miltenyi, S. (2020). SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature, [online] 587(7833), pp.270–274. Available at: https://www.nature.com/articles/s41586-020-2598-9 [Accessed 21 Dec. 2020].
Chandrashekar, A., Liu, J., Martinot, A.J., McMahan, K., Mercado, N.B., Peter, L., Tostanoski, L.H., Yu, J., Maliga, Z., Nekorchuk, M., Busman-Sahay, K., Terry, M., Wrijil, L.M., Ducat, S., Martinez, D.R., Atyeo, C., Fischinger, S., Burke, J.S., Slein, M.D. and Pessaint, L. (2020). SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. [online] Available at: https://science.sciencemag.org/content/early/2020/05/19/science.abc4776.
Corbett, K.S., Edwards, D., Leist, S.R., Abiona, O.M., Boyoglu-Barnum, S., Gillespie, R.A., Himansu, S., Schäfer, A., Ziwawo, C.T., DiPiazza, A.T., Dinnon, K.H., Elbashir, S.M., Shaw, C.A., Woods, A., Fritch, E.J., Martinez, D.R., Bock, K.W., Minai, M., Nagata, B.M. and Hutchinson, G.B. (2020). SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness. bioRxiv.
Giménez, E., Albert, E., Torres, I., Remigia, M.J., Alcaraz, M.J., Galindo, M.J., Blasco, M.L., Solano, C., Forner, M.J., Redón, J., Signes‐Costa, J. and Navarro, D. (2020). SARS‐CoV‐2‐reactive interferon‐γ‐producing CD8+ T cells in patients hospitalized with coronavirus disease 2019. Journal of Medical Virology, 93(1), pp.375–382.
Jackson, L.A., Anderson, E.J., Rouphael, N.G., Roberts, P.C., Makhene, M., Coler, R.N., McCullough, M.P., Chappell, J.D., Denison, M.R., Stevens, L.J., Pruijssers, A.J., McDermott, A., Flach, B., Doria-Rose, N.A., Corbett, K.S., Morabito, K.M., O’Dell, S., Schmidt, S.D., Swanson, P.A. and Padilla, M. (2020). An mRNA Vaccine against SARS-CoV-2 — Preliminary Report. New England Journal of Medicine.
McKay, P.F., Hu, K., Blakney, A.K., Samnuan, K., Brown, J.C., Penn, R., Zhou, J., Bouton, C.R., Rogers, P., Polra, K., Lin, P.J.C., Barbosa, C., Tam, Y.K., Barclay, W.S. and Shattock, R.J. (2020). Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice. Nature Communications, 11(1).
Neidleman, J., Luo, X., Frouard, J., Xie, G., Gill, G., Stein, E.S., McGregor, M., Ma, T., George, A., Kosters, A., Greene, W.C., Vasquez, J., Ghosn, E., Lee, S. and Roan, N.R. (2020). SARS-CoV-2-specific T cells exhibit unique features reflecting robust helper function, lack of terminal differentiation, and high proliferative potential. bioRxiv. [online] Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302219/ [Accessed 18 Feb. 2021].
Payen, D., Cravat, M., Maadadi, H., Didelot, C., Prosic, L., Dupuis, C., Losser, M.-R. and De Carvalho Bittencourt, M. (2020). A Longitudinal Study of Immune Cells in Severe COVID-19 Patients. Frontiers in Immunology, 11.
Sahin, U., Muik, A., Derhovanessian, E., Vogler, I., Kranz, L.M., Vormehr, M., Baum, A., Pascal, K., Quandt, J., Maurus, D., Brachtendorf, S., Loerks, V.L., Sikorski, J., Hilker, R., Becker, D., Eller, A.-K., Gruetzner, J., Boesler, C., Rosenbaum, C. and Kuehnle, M.-C. (2020). Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine. medRXiv.
Stamatakis, G., Samiotaki, M., Mpakali, A., Panayotou, G. and Stratikos, E. (2020). Generation of SARS-CoV-2 S1 Spike Glycoprotein Putative Antigenic Epitopes in Vitro by Intracellular Aminopeptidases. Journal of Proteome Research, 19(11), pp.4398–4406.
Zecha, J., Lee, C.-Y., Bayer, F.P., Meng, C., Grass, V., Zerweck, J., Schnatbaum, K., Michler, T., Pichlmair, A., Ludwig, C. and Kuster, B. (2020). Data, Reagents, Assays and Merits of Proteomics for SARS-CoV-2 Research and Testing. Molecular & cellular proteomics: MCP, [online] 19(9), pp.1503–1522. Available at: https://pubmed.ncbi.nlm.nih.gov/32591346/ [Accessed 18 Feb. 2021].